Brief: Four Year Follow-Up Data From Profound Medical’S Tact Pivotal Clinical Trial Confirm Durable And Stable Positive Trends Following Treatment With Tulsa-Pro® Of Men With Localized Prostate Cancer

Profound Medical

26/09/2022 14:28

Sept 26 (Reuters) - Profound Medical Corp  PRN.TO :
    * FOUR YEAR FOLLOW-UP DATA FROM PROFOUND MEDICAL’S TACT
PIVOTAL
CLINICAL TRIAL CONFIRM DURABLE AND STABLE POSITIVE TRENDS
FOLLOWING TREATMENT WITH TULSA-PRO® OF MEN WITH LOCALIZED
PROSTATE CANCER

Source text for Eikon:  ID:nGNX2JtGgh 
Further company coverage:  PRN.TO 
 ((Reuters.Briefs@thomsonreuters.com;;))